(Q38097351)

28 August 2017

The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations (English)

1 reference

28 August 2017

0 references

1 reference

Gudmundur Johannsson

4

0 references

Edward O List

series ordinal

3

object named as

Edward O List

1 reference

28 August 2017

Darlene E Berryman

1

1 reference

PubMed ID

23568441

28 August 2017

Camilla A M Glad

series ordinal

2

1 reference

28 August 2017

9 April 2013

1 reference

Nature Reviews Endocrinology

28 August 2017

1 reference

28 August 2017

9

1 reference

28 August 2017

6

1 reference

28 August 2017

346-356

1 reference

https://scigraph.springernature.com/pub.10.1038/nrendo.2013.64

28 August 2017

0 references

cites work

Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

EFFECT OF HUMAN GROWTH HORMONE ON MUSCLE AND ADIPOSE TISSUE METABOLISM IN THE FOREARM OF MAN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Management of adult growth hormone deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a Metaanalysis of Blinded, Randomized, Placebo-Controlled Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Abdominal visceral fat and fasting insulin are important predictors of 24-hour GH release independent of age, gender, and other physiological factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Metabolic effects and pharmacokinetics of a growth hormone pulse in healthy adults: relation to age, sex, and body composition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

A novel effect of growth hormone on macrophage modulates macrophage-dependent adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Growth hormone and prolactin receptors in adipogenesis: STAT-5 activation, suppressors of cytokine signaling, and regulation of insulin-like growth factor I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Dose-specific or dose-dependent effect of growth hormone treatment on the proliferation and differentiation of cultured neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Expression, regulation and biological actions of growth hormone (GH) and ghrelin in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Gene expression of the GH receptor in subcutaneous and intraabdominal fat in healthy females: relationship to GH-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

The mechanism of effect of growth hormone on preadipocyte and adipocyte function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

The insulin-like growth factors in adipogenesis and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Aging, depot origin, and preadipocyte gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Identification of depot-specific human fat cell progenitors through distinct expression profiles and developmental gene patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Clinical relevance of adipokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

The somatotrope as a metabolic sensor: deletion of leptin receptors causes obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Human BAT possesses molecular signatures that resemble beige/brite cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Ablation of ghrelin receptor reduces adiposity and improves insulin sensitivity during aging by regulating fat metabolism in white and brown adipose tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Architecture and the extracellular matrix: the still unappreciated components of the adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Gene expression in visceral and subcutaneous adipose tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Adipose tissue heterogeneity: implication of depot differences in adipose tissue for obesity complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Adipose tissue remodeling and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Growth hormone and adipose tissue: beyond the adipocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Abdominal adiposity and physical fitness are major determinants of the age associated decline in stimulated GH secretion in healthy adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Peak growth hormone-releasing hormone-arginine-stimulated growth hormone is inversely associated with intramyocellular and intrahepatic lipid content in premenopausal women with obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Thigh intermuscular fat is inversely associated with spontaneous GH release in post-menopausal women with abdominal obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Growth hormone (GH) status is an independent determinant of serum levels of cholesterol and triglycerides in healthy adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Impact of abdominal visceral fat, growth hormone, fitness, and insulin on lipids and lipoproteins in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Growth hormone deficiency by growth hormone releasing hormone-arginine testing criteria predicts increased cardiovascular risk markers in normal young overweight and obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

The effects of central adiposity on growth hormone (GH) response to GH-releasing hormone-arginine stimulation testing in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Organization and evolution of the human growth hormone receptor gene 5'-flanking region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

GHR exon 3 polymorphism: Association with type 2 diabetes mellitus and metabolic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

The growth hormone receptor (GHR) exon 3 polymorphism and its correlation with metabolic profiles in obese Chinese children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Effects of Triiodothyronine, Growth Hormone and Anabolic Steroids on Nitrogen Excretion and Oxygen Consumption of Obese Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Growth hormone administration conserves lean body mass during dietary restriction in obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a 12-month placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Low-dose physiological growth hormone in patients with HIV and abdominal fat accumulation: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Roles of insulin-like growth factor-I and growth hormone in mediating insulin resistance in acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Evidence against a role for insulin-signaling proteins PI 3-kinase and Akt in insulin resistance in human skeletal muscle induced by short-term GH infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Growth hormone signaling in vivo in human muscle and adipose tissue: impact of insulin, substrate background, and growth hormone receptor blockade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Growth hormone regulation of p85alpha expression and phosphoinositide 3-kinase activity in adipose tissue: mechanism for growth hormone-mediated insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Growth hormone and changes in energy balance in growth hormone deficient adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Healthcare consumption decreases in parallel with improvements in quality of life during GH replacement in hypopituitary adults with GH deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Low-dose recombinant human growth hormone as adjuvant therapy to lifestyle modifications in the management of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Regulation of lipoprotein lipase and hormone-sensitive lipase activity and gene expression in adipose and muscle tissue by growth hormone treatment during weight loss in obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Metabolic effects of a growth hormone-releasing factor in obese subjects with reduced growth hormone secretion: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Effects of growth hormone and pioglitazone in viscerally obese adults with impaired glucose tolerance: a factorial clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Effects of GH in women with abdominal adiposity: a 6-month randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Effects of recombinant human growth hormone therapy in obesity in adults: a meta analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Effects of a combination of recombinant human growth hormone with metformin on glucose metabolism and body composition in patients with metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Metabolic effects of a growth hormone-releasing factor in patients with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Plasma proteomic profiles of bovine growth hormone transgenic mice as they age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Role of the GH/IGF-1 axis in lifespan and healthspan: lessons from animal models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Transgenic models of growth hormone action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Comparing adiposity profiles in three mouse models with altered GH signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Growth hormone overexpression in the central nervous system results in hyperphagia-induced obesity associated with insulin resistance and dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Adipocytokines and the regulation of lipid metabolism in growth hormone transgenic and calorie-restricted mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Bovine growth hormone transgenic mice are resistant to diet-induced obesity but develop hyperphagia, dyslipidemia, and diabetes on a high-fat diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Can Growth Hormone (GH) Accelerate Aging? Evidence from GH-Transgenic Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Elevated GH/IGF-I, due to somatotrope-specific loss of both IGF-I and insulin receptors, alters glucose homeostasis and insulin sensitivity in a diet-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Endocrine parameters and phenotypes of the growth hormone receptor gene disrupted (GHR-/-) mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Impact of reduced insulin-like growth factor-1/insulin signaling on aging in mammals: novel findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Two-year body composition analyses of long-lived GHR null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Growth hormone receptor deficiency results in blunted ghrelin feeding response, obesity, and hypolipidemia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Developmental aspects of adipose tissue in GH receptor and prolactin receptor gene disrupted mice: site-specific effects upon proliferation, differentiation and hormone sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Long-lived growth hormone receptor knockout mice show a delay in age-related changes of body composition and bone characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Disruption of growth hormone receptor gene causes diminished pancreatic islet size and increased insulin sensitivity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Metabolic effects of intra-abdominal fat in GHRKO mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Adiponectin in mice with altered GH action: links to insulin sensitivity and longevity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Caloric restriction results in decreased expression of peroxisome proliferator-activated receptor superfamily in muscle of normal and long-lived growth hormone receptor/binding protein knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Daily energy balance in growth hormone receptor/binding protein (GHR -/-) gene-disrupted mice is achieved through an increase in dark-phase energy efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

The role of GH in adipose tissue: lessons from adipose-specific GH receptor gene-disrupted mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

The decline in pulsatile GH secretion throughout early adulthood in mice is exacerbated by dietary-induced weight gain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Growth hormone improves body composition, fasting blood glucose, glucose tolerance and liver triacylglycerol in a mouse model of diet-induced obesity and type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Effects of growth hormone (GH) on mRNA levels of uncoupling proteins 1, 2, and 3 in brown and white adipose tissues and skeletal muscle in obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Free fatty acids block growth hormone (GH) releasing hormone-stimulated GH secretion in man directly at the pituitary

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Pharmacological antilipolysis restores insulin sensitivity during growth hormone exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

GH-dependent STAT5 signaling plays an important role in hepatic lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Identification of inducible brown adipocyte progenitors residing in skeletal muscle and white fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Fibrosis in human adipose tissue: composition, distribution, and link with lipid metabolism and fat mass loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

CIDE-A gene expression is decreased in white adipose tissue of growth hormone receptor/binding protein gene disrupted mice and with high-fat feeding of normal mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Exogenous human growth hormone reduces body fat in obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Metabolic impact of adult-onset, isolated, growth hormone deficiency (AOiGHD) due to destruction of pituitary somatotropes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

The Ames dwarf gene is required for Pit-1 gene activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Body composition of prolactin-, growth hormone, and thyrotropin-deficient Ames dwarf mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Growth hormone deficiency in 'little' mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2, -1 or -4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Nonalcoholic fatty liver disease in adult hypopituitary patients with GH deficiency and the impact of GH replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Calorigenic effect of human growth hormone in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Growth hormone and hepatic lipoprotein metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Growth hormone and the heart

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Consensus Guidelines for the Diagnosis and Treatment of Adults with Growth Hormone Deficiency: Summary Statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Human growth hormone receptor (GHR) expression in obesity: I. GHR mRNA expression in omental and subcutaneous adipose tissues of obese women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Truncal adiposity, relative growth hormone deficiency, and cardiovascular risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Blunted lipolytic response to fasting in abdominally obese women: evidence for involvement of hyposomatotropism.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Treatment of obese, diet-restricted subjects with growth hormone for 11 weeks: effects on anabolism, lipolysis, and body composition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Anabolic effects of growth hormone in obese diet-restricted subjects are dose dependent

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Metabolic effects of biosynthetic growth hormone treatment in severely energy-restricted obese women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Fuel metabolism, energy expenditure, and thyroid function in growth hormone-treated obese women: a double-blind placebo-controlled study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Effects of growth hormone treatment on the leptin system and on energy expenditure in abdominally obese men

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Effects of growth hormone therapy on thyroid function of growth hormone-deficient adults with and without concomitant thyroxine-substituted central hypothyroidism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Growth Hormone Reduces Inflammation in Postmenopausal Women with Abdominal Obesity: A 12-Month, Randomized, Placebo-Controlled Trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Increased P85alpha is a potent negative regulator of skeletal muscle insulin signaling and induces in vivo insulin resistance associated with growth hormone excess

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Persistent lipolytic effect of exogenous growth hormone during caloric restriction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Growth hormone (GH)-induced insulin resistance is rapidly reversible: an experimental study in GH-deficient adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Expression of Insulin-Like Growth Factor I in Transgenic Mice with Elevated Levels of Growth Hormone Is Correlated with Growth*

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Effect of growth hormone on susceptibility to diet-induced obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Enlargement of interscapular brown adipose tissue in growth hormone antagonist transgenic and in growth hormone receptor gene-disrupted dwarf mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Diet-induced type II diabetes in C57BL/6J mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

The intricate role of growth hormone in metabolism.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Growth hormone administration in addition to a very low calorie diet and an exercise program in obese subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Glycine 119 of bovine growth hormone is critical for growth-promoting activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Adipocytokines and lipid levels in Ames dwarf and calorie-restricted mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.64

Treatment of Obese Subjects with the Oral Growth Hormone Secretagogue MK-677 Affects Serum Concentrations of Several Lipoproteins, But Not Lipoprotein(a)

31 March 2020

1 reference

12 December 2020

Abdominal adiposity rather than age and sex predicts mass and regularity of GH secretion in healthy adults.

1 reference

12 December 2020

Growth hormone treatment of obese women for 5 wk: effect on body composition and adipose tissue LPL activity

1 reference

12 December 2020

Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice

1 reference

12 December 2020

Insulin regulation of human hepatic growth hormone receptors: divergent effects on biosynthesis and surface translocation

1 reference

12 December 2020

Gene expression of a truncated and the full-length growth hormone (GH) receptor in subcutaneous fat and skeletal muscle in GH-deficient adults: impact of GH treatment

1 reference

12 December 2020

Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure

1 reference

12 December 2020

Energy and macronutrient intake in growth hormone-deficient adults: the effect of growth hormone replacement

1 reference

12 December 2020

Effects of growth hormone on insulin resistance and atherosclerotic risk factors in obese type 2 diabetic patients with poor glycaemic control.

1 reference

12 December 2020

Treatment of adults with growth hormone (GH) deficiency with recombinant human GH

1 reference

12 December 2020

Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency

1 reference

12 December 2020

Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure.

1 reference

12 December 2020

Low-dose growth hormone treatment with diet restriction accelerates body fat loss, exerts anabolic effect and improves growth hormone secretory dysfunction in obese adults

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRENDO.2013.64

1 reference

28 August 2017

1 reference

PubMed ID

23568441